Nothing Special   »   [go: up one dir, main page]

TR200906322A2 - Granules with improved solubility and stability properties. - Google Patents

Granules with improved solubility and stability properties.

Info

Publication number
TR200906322A2
TR200906322A2 TR2009/06322A TR200906322A TR200906322A2 TR 200906322 A2 TR200906322 A2 TR 200906322A2 TR 2009/06322 A TR2009/06322 A TR 2009/06322A TR 200906322 A TR200906322 A TR 200906322A TR 200906322 A2 TR200906322 A2 TR 200906322A2
Authority
TR
Turkey
Prior art keywords
improved solubility
granules
stability properties
stability
properties
Prior art date
Application number
TR2009/06322A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/06322A priority Critical patent/TR200906322A2/en
Priority to PCT/TR2010/000167 priority patent/WO2011034513A1/en
Priority to EP10801007A priority patent/EP2467129A1/en
Publication of TR200906322A2 publication Critical patent/TR200906322A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, tek başına veya HCTZ gibi bir terapotik ajanla kombinasyon halindeki ramiprili içeren çözünürlük ve stabilite özellikleri geliştirilmiş farmasötik bileşimlere, bu bileşimlerin hazırlanma yöntemine ve tıbbi kullanımına ilişkindirThe present invention relates to pharmaceutical compositions with improved solubility and stability properties, method of preparation and medical use of ramipril alone or in combination with a therapeutic agent such as HCTZ.

TR2009/06322A 2009-08-17 2009-08-17 Granules with improved solubility and stability properties. TR200906322A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2009/06322A TR200906322A2 (en) 2009-08-17 2009-08-17 Granules with improved solubility and stability properties.
PCT/TR2010/000167 WO2011034513A1 (en) 2009-08-17 2010-08-13 The granules with improved solubility and stability
EP10801007A EP2467129A1 (en) 2009-08-17 2010-08-13 The granules with improved solubility and stability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/06322A TR200906322A2 (en) 2009-08-17 2009-08-17 Granules with improved solubility and stability properties.

Publications (1)

Publication Number Publication Date
TR200906322A2 true TR200906322A2 (en) 2011-07-21

Family

ID=43568838

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/06322A TR200906322A2 (en) 2009-08-17 2009-08-17 Granules with improved solubility and stability properties.

Country Status (3)

Country Link
EP (1) EP2467129A1 (en)
TR (1) TR200906322A2 (en)
WO (1) WO2011034513A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163579B2 (en) * 2004-04-14 2007-01-16 H.B. Fuller Licensing & Financing Inc. Method of making water resistant corrugated boards

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025292A (en) 1962-03-13 Reduction of i
DE3226768A1 (en) 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt DERIVATIVES OF CIS, ENDO-2-AZABICYCLO- (3.3.0) -OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
DE3739690A1 (en) 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
CN1144598C (en) 1998-06-05 2004-04-07 沃尼尔·朗伯公司 Stabilization of compositions containing ACE inhibitors using magnesium oxide
US20030225124A1 (en) 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
CA2357982A1 (en) 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
DE60312857T2 (en) 2002-01-15 2008-01-17 Actavis Group Hf. FORMULATIONS OF QUINAPRIL AND RELATED ACE INHIBITORS
MXPA04006892A (en) 2002-01-15 2004-10-15 Ranbaxy Lab Ltd Stable pharmaceutical compositions comprising ace inhibitor(s).
US20030215526A1 (en) 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
WO2004064809A1 (en) 2003-01-22 2004-08-05 Sandoz Ag Solid pharmaceutical composition comprising ramipril
PL1635792T3 (en) 2003-06-26 2009-08-31 Teva Pharmaceutical Industries Ltd Stable pharmaceutical compositions of 2-aza-bicyclo¬3.3.0 -octane-3-carboxylic acid derivatives
GB2404336A (en) 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
AU2003300692A1 (en) 2003-10-30 2005-05-19 Lupin Ltd. Stable formulations of ace inhibitors and methods for preparation thereof
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1734931A2 (en) 2004-03-24 2006-12-27 Actavis Group Formulations of ramipril
US20060045911A1 (en) 2004-08-27 2006-03-02 Sun Pharmaceutical Industries Ltd. Stable pharmaceutical formulations
EP1824451A2 (en) 2004-11-05 2007-08-29 King Pharmaceuticals Research and Development Inc. Stabilized ramipril compositions and methods of making
WO2007056442A1 (en) 2005-11-07 2007-05-18 King Pharmaceuticals Research & Development, Inc. Compositions of stabilized ramipril in combination with another active agent
WO2008001184A2 (en) 2006-06-26 2008-01-03 Emcure Pharmaceuticals Limited Solid composition
US20100035955A1 (en) 2006-06-30 2010-02-11 Panagiotis Keramidas Stabilised Composition Comprising ACE Inhibitors
GB0624087D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
PL382311A1 (en) 2007-04-27 2008-11-10 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Pharmaceutical composition with improved stability containing inhibitor of acethylolinoesterasis or its pharmaceutically admitted salt and its production method
WO2008132756A1 (en) 2007-05-01 2008-11-06 Lupin Limited Stable pharmaceutical compositions of ramipril

Also Published As

Publication number Publication date
WO2011034513A1 (en) 2011-03-24
EP2467129A1 (en) 2012-06-27

Similar Documents

Publication Publication Date Title
MX2011008634A (en) Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy.
CY1119616T1 (en) HUMAN ANTI-DUMP DRUG CONSUMPTION AGAINST TISSUE
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
MX2014009757A (en) Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy.
JO3416B1 (en) Antimicrobial compositions and related methods of use
MX2009014235A (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy.
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
NZ595372A (en) Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
IN2012DN01233A (en)
EA201100971A1 (en) DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
JO3366B1 (en) Pyrazolyl quinoxaline kinase inhibitors
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
MX2011009847A (en) Anthelmintic agents and their use.
PH12014500386A1 (en) Combination treatment for hepatitis c
TR200806298A2 (en) Pharmaceutical formulation
UA109037C2 (en) Triazolepyridins
MX347105B (en) Pharmaceutical compositions comprising hydromorphone and naloxone.
MX342947B (en) Treatment of type 2 diabetes.
MX344846B (en) COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS.
MX2015011614A (en) Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy.
EP2532665A4 (en) Benzimidazole derivatives and pharmaceutical compositions thereof and uses thereof
GEP20135859B (en) Stable combined pharmaceutical composition
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.